QIAGEN : to embrace global initiative to combat antibiotic resistance and launches cutting-edge QIAGEN Microbial Insights AR
QIAGEN today announced a new initiative to help address the global crisis of antibiotic-resistant pathogens. The Company will commit resources to support biomarker research and participate in the U.S. Centers for Disease Control and Prevention (CDC) Antimicrobial Resistance (AMR) Challenge. As a first response, QIAGEN is launching QIAGEN Microbial Insights AR (QMI-AR), an integrated genomic database that provides curated, single-point of entry access to four of the world’s largest knowledge bases on antimicrobial resistance.
Emerging Antimicrobials and Diagnostics in AMR 2023
International Matchmaking Symposium EADA 2023
Amsterdam, The Netherlands